News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
223,728 Results
Type
Article (7138)
Company Profile (18)
Press Release (216572)
Section
Business (63156)
Career Advice (294)
Deals (14782)
Drug Delivery (26)
Drug Development (36798)
Employer Resources (24)
FDA (6417)
Job Trends (4906)
News (121872)
Policy (11636)
Tag
Academia (568)
Alliances (14691)
Alzheimer's disease (558)
Approvals (6418)
Artificial intelligence (58)
Bankruptcy (144)
Best Places to Work (4581)
Breast cancer (75)
Cancer (710)
Cardiovascular disease (48)
Career advice (257)
CAR-T (53)
Cell therapy (145)
Clinical research (30502)
Collaboration (179)
Compensation (49)
COVID-19 (701)
C-suite (43)
Data (861)
Diabetes (71)
Diagnostics (2156)
Earnings (32487)
Events (30271)
Executive appointments (142)
FDA (6783)
Funding (149)
Gene therapy (88)
GLP-1 (145)
Government (1246)
Healthcare (6130)
Infectious disease (743)
Inflammatory bowel disease (50)
Interviews (45)
IPO (7955)
Job creations (571)
Job search strategy (220)
Legal (2089)
Lung cancer (91)
Lymphoma (51)
Manufacturing (70)
Medical device (4539)
Medtech (4540)
Mergers & acquisitions (6975)
Metabolic disorders (181)
Neuroscience (674)
NextGen Class of 2024 (1502)
Non-profit (711)
Northern California (835)
Obesity (100)
Opinion (67)
Parkinson's disease (38)
Patents (68)
People (14266)
Phase I (9694)
Phase II (13429)
Phase III (10075)
Pipeline (343)
Postmarket research (796)
Preclinical (3543)
Radiopharmaceuticals (115)
Rare diseases (111)
Real estate (1001)
Regulatory (8886)
Research institute (510)
Resumes & cover letters (39)
Southern California (717)
Startups (678)
United States (6993)
Vaccines (121)
Weight loss (59)
Date
Last 7 days (156)
Last 30 days (1101)
Last 365 days (16914)
2024 (16873)
2023 (19105)
2022 (22310)
2021 (23684)
2020 (21849)
2019 (14473)
2018 (10673)
2017 (11482)
2016 (9566)
2015 (11762)
2014 (8122)
2013 (5906)
2012 (6060)
2011 (6765)
2010 (6233)
Location
Africa (174)
Asia (17313)
Australia (4794)
California (1830)
Canada (825)
China (139)
Colorado (74)
Connecticut (105)
Europe (27445)
Florida (256)
Georgia (43)
Illinois (132)
Indiana (88)
Japan (51)
Maryland (236)
Massachusetts (1361)
Michigan (40)
Minnesota (69)
New Jersey (654)
New York (588)
North Carolina (297)
Northern California (835)
Ohio (43)
Pennsylvania (459)
South America (300)
Southern California (717)
Texas (270)
Utah (44)
Virginia (41)
Washington State (271)
223,728 Results for "cochlear limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cochlear receives FDA clearance to lower the age for the Osia System to 5-years-old
Cochlear Limited (ASX: COH) obtained U.S. Food and Drug Administration (FDA) clearance to lower the age of the Cochlear™ Osia System from 12 years-old to 5-years-old for children with conductive hearing loss, mixed hearing loss and single-sided sensorineural deafness (SSD).
April 19, 2024
·
4 min read
Sensorion Announces Upcoming Presentation of Promising SENS-401 Results at the Next International Conference on Cochlear Implants and Other Implantable Technologies
Sensorion announces that promising new data and analysis results from the SENS-401 following cochlear implantation Phase 2a clinical study will be presented at the 17th International Conference on Cochlear Implants and Other Implantable Technologies taking place on July 10-13, 2024, in Vancouver, Canada.
June 20, 2024
·
5 min read
BioForest
Sound Pharmaceuticals’ IND Involving Cochlear Implantation Allowed by the FDA
Sound Pharmaceuticals (SPI) is pleased to announce that it has received FDA notification that its Investigational New Drug Application (IND) may proceed involving SPI-1005 treatment and cochlear implantation (CI).
May 20, 2024
·
3 min read
Drug Development
Sensorion Announces the Completion of Patient Inclusion in Phase 2a Clinical Trial of SENS-401 for Residual Hearing Preservation After Cochlear Implantation
Sensorion announces the recruitment of the last patient in its Phase 2a clinical trial of SENS-401 for residual hearing preservation in adult patients following cochlear implantation.
February 1, 2024
·
5 min read
Cochlear™ Osia® System becomes industry’s first active bone conduction system to enable MRI at 3 Tesla
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, introduces its next generation Cochlear™ Osia® System with the ability to have an MRI at 3.0 T, designed to improve hearing outcomes for people with conductive hearing loss, mixed hearing loss and single-sided sensorineural deafness (SSD).
August 18, 2023
·
5 min read
BioMidwest
New Clinical Publication Reports First Three Patients in Early Feasibility Trial for Envoy Medical’s Fully Implanted Cochlear Device
A recent clinical publication in the Journal of Clinical Medicine (JCM) highlighted early surgical experience with Envoy Medical®, Inc.’s (“Envoy Medical”) (NASDAQ: “COCH”) investigational Acclaim® fully implantable cochlear implant.
October 19, 2023
·
8 min read
FDA
FDA approves Cochlear’s Nucleus 8 Sound Processor, smaller, smarter, better connected cochlear implant technology
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, receives U.S. Food and Drug Administration (FDA) approval for the Cochlear™ Nucleus® 8 Sound Processor.
November 1, 2022
·
7 min read
Press Releases
Dynavax Adopts Limited-Duration Stockholder Rights Plan
October 30, 2024
·
5 min read
Press Releases
IMFINZI® (durvalumab) approved in the US as first and only immunotherapy regimen for patients with limited-stage small cell lung cancer
December 5, 2024
·
19 min read
Business
Advanced Bionics Announces New President and Management Board Member
Advanced Bionics is pleased to announce the appointment of Alistair Simpson as its new president, and Group Vice President (GVP) for cochlear implants on the Sonova Management Board, effective immediately.
July 1, 2024
·
3 min read
1 of 22,373
Next
